Publikationen von Matthaeus Vasel

Altrock, E.; Sens, C.; Wuerfel, C.; Vasel, M.; Kawelke, N.; Dooley, S.; Sottile, J.; Nakchbandi, I.: Erratum to “Inhibition of fibronectin deposition improves experimental liver fibrosis” [J Hepatol 2015;62:625–633]. JOURNAL OF HEPATOLOGY 62 (6), S. 1455 - 1456 (2015)

Altrock, E.; Sens, C.; Wuerfel, C.; Vasel, M.; Kawelke, N.; Dooley, S.; Sottile, J.; Nakchbandi, I.: Inhibition of fibronectin deposition improves experimental liver fibrosis. Journal of Hepatology 62 (3), S. 625 - 633 (2015)

Vasel, M.; Rutz, R.; Bersch, C.; Feick, P.; Singer, M. V.; Kirschfink, M.; Nakchbandi, I. A.: Complement activation correlates with liver necrosis and fibrosis in chronic hepatitis C. CLINICAL IMMUNOLOGY 150 (2), S. 149 - 156 (2014)

Rossnagl, S.; von Au, A.; Vasel, M.; Cecchini, A. G.; Nakchbandi, I. A.: Blood Clot Formation Does Not Affect Metastasis Formation or Tumor Growth in a Murine Model of Breast Cancer. PLOS ONE 9 (4), e94922 (2014)

von Au, A.; Vasel, M.; Kraft, S.; Sens, C.; Hackl, N.; Marx, A.; Stroebel, P.; Hennenlotter, J.; Todenhoefer, T.; Stenzl, A. et al.; Schott, S.; Sinn, H.-P.; Wetterwald, A.; Bermejo, J. L.; Cecchini, M. G.; Nakchbandi, I. A.: Circulating Fibronectin Controls Tumor Growth. NEOPLASIA 15 (8), S. 925 - 938 (2013)

Kawelke, N.; Vasel, M.; Sens, C.; von Au, A.; Dooley, S.; Nakchbandi, I. A.: Fibronectin Protects from Excessive Liver Fibrosis by Modulating the Availability of and Responsiveness of Stellate Cells to Active TGF-beta. PLoS ONE 6 (11), e28181, S. [1] - [14] (2011)

Kawelke, N.; Vasel, M.; Nakchbandi, I.: FIBRONECTIN IN THE LIVER MODIFIES SEVERITY OF LIVER FIBROSIS. Journal of Hepatology 54 (Suppl. 1), S. 1040 - 1040 (2011)

von Au, A.; Vasel, M.; Cecchini, M.; Nakchbandi, I. A.: The role of fibronectin originating from different sources on breast cancer metastasis development and bone remodeling. Bone 48 (1 Sp. Iss.), S. S50 - S50 (2011)

Hackl, N.; von Au, A.; Vasel, M.; Tiwari, S.; Cecchini, M. G.; Nakchbandi, I. A.: The role of fibronectin in the bone marrow metastatic niches. Bone 47 (Suppl. 2), S. S263 - S264 (2010)

von Au, A.; Vasel, M.; Kraft, S.; Cecchini, M. G.; Wetterwald, A.; Nakchbandi, I.: Circulating fibronectin increases tumor growth and fibronectin content of tumors correlates with survival. In Bone, 50 (Suppl. 1), S. S50 - S51. ELSEVIER SCIENCE INC, NEW YORK (2012)

Kawelke, N.; Kraft, S.; Vasel, M.; Nakchbandi, I. A.: Beta1 integrin expression in osteoblast progenitors is required for bone formation. In Bone, 48 (Suppl. 2), S. S118 - S118. ELSEVIER SCIENCE INC, NEW YORK (2011)

von Au, A.; Vasel, M.; Glueer, C. C.; Tiwari, S.; Cecchini, M. G.; Nakchbandi, I. A.: Circulating fibronectin is required for blood vessel formation and tumor growth. In Bone, 48 (Suppl. 2), S. S251 - S251. ELSEVIER SCIENCE INC, NEW YORK (2011)